EZH2 Regulates microRNA-31 Expression in Colorectal Cancer and May Affect Differentiation and Evolution of the Serrated Pathway

被引:0
|
作者
Yamamoto, Itaru
Ishigami, Keisuke
Kurihara, Hiroyoshi
Maruyama, Reo
Kanno, Shinichi
Ishiguro, Kazuya
Mitsuhashi, Kei
Igarashi, Hisayoshi
Ito, Miki
Tanuma, Tokuma
Sukawa, Yasutaka
Shinomura, Yasuhisa
Imai, Kohzoh
Yamamoto, Hiroyuki
Nosho, Katsuhiko
机构
关键词
D O I
10.1016/S0016-5085(16)31256-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1727
引用
收藏
页码:S358 / S358
页数:1
相关论文
共 50 条
  • [31] Prognostic value of high EZH2 expression in patients with colorectal cancer in East Azerbaijan, Iran
    Sanaat, Z.
    Dolatkhah, R.
    Gholami, N.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [32] Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer
    Yan-Long Liu
    Xu Gao
    Yang Jiang
    Gan Zhang
    Zi-Cheng Sun
    Bin-Bin Cui
    Yan-Mei Yang
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 661 - 669
  • [33] Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
    Fluge, O.
    Gravdal, K.
    Carlsen, E.
    Vonen, B.
    Kjellevold, K.
    Refsum, S.
    Lilleng, R.
    Eide, T. J.
    Halvorsen, T. B.
    Tveit, K. M.
    Otte, A. P.
    Akslen, L. A.
    Dahl, O.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1282 - 1289
  • [34] Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
    Ø Fluge
    K Gravdal
    E Carlsen
    B Vonen
    K Kjellevold
    S Refsum
    R Lilleng
    T J Eide
    T B Halvorsen
    K M Tveit
    A P Otte
    L A Akslen
    O Dahl
    [J]. British Journal of Cancer, 2009, 101 : 1282 - 1289
  • [35] Dysregulated Expression of Long Non-Coding RNA MINCR and EZH2 in Colorectal Cancer
    Cheraghi, Sajjad
    Asadzadeh, Hamid
    Javadi, GholamReza
    [J]. IRANIAN BIOMEDICAL JOURNAL, 2022, 26 (01) : 64 - 69
  • [36] EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
    Wang, Cheng-Gang
    Ye, Ying-Jiang
    Yuan, Jing
    Liu, Fang-Fang
    Zhang, Hui
    Wang, Shan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (19) : 2421 - 2427
  • [37] MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2
    Zhou, Fenmei
    Chen, Juan
    Wang, Hairong
    [J]. ONCOLOGY LETTERS, 2016, 12 (05) : 3926 - 3932
  • [38] BLM interaction with EZH2 regulates MDM2 expression and is a poor prognostic biomarker for prostate cancer
    Ruan, Yong
    Xu, Houqiang
    Ji, Xinqin
    Zhao, Jiafu
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (04): : 1347 - 1368
  • [39] EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
    Guo, Jianfeng
    Cai, Jing
    Yu, Lili
    Tang, Huijuan
    Chen, Chunyan
    Wang, Zehua
    [J]. CANCER SCIENCE, 2011, 102 (03) : 530 - 539
  • [40] lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer
    Xu, Mu
    Chen, Xiaoxiang
    Lin, Kang
    Zeng, Kaixuan
    Liu, Xiangxiang
    Xu, Xueni
    Pan, Bei
    Xu, Tao
    Sun, Li
    He, Bangshun
    Pan, Yuqin
    Sun, Huiling
    Wang, Shukui
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)